Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association
about
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II studyAcute myeloid leukemia stem cells and CD33-targeted immunotherapyAntibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicinAcute myelogenous leukemia stem cells: from Bench to Bedside.Current strategies in immunotherapy for acute myeloid leukemia.Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.Gemtuzumab ozogamicin in acute myeloid leukemia revisited.Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.Outcome of older patients with acute myeloid leukemia in first relapse.The addition of gemtuzumab ozogamicin to chemotherapy in adult patients with acute myeloid leukemia.Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia.
P2860
Q33412354-6E76EC6A-F2F5-448B-B576-66D3F276F5FEQ33558088-6DC94EDD-98D1-4B5A-A1BC-58FC1DAC2C48Q36058588-A8283E49-89FB-4D58-9A32-BED21B1C7F92Q36932014-026087BA-7744-49A3-9AA5-FFB167B462C3Q38020081-ACA348D6-70F7-4156-8067-AC6DB7424D69Q38068967-B4480F91-7DDD-41F3-97AE-2501C74DA9ECQ38155455-D9B32F17-9059-46D7-8C4A-D813601C3568Q38215269-640597C3-A27B-4B68-9E64-C5A777F67454Q39311595-6FEC4FEA-C3F8-42D5-B7D5-0A90ABE8F733Q39405204-2B206D2E-3D2D-493F-973A-7A8528DE3A2CQ40872029-B4E479F6-CC05-4B4B-B15D-179E56027E2EQ44462005-14F1474B-C237-4262-B86B-B6A1544F15AB
P2860
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association
description
article
@en
im November 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2011
@uk
name
Fractionated doses of gemtuzum ...... te leukemia French association
@en
Fractionated doses of gemtuzum ...... te leukemia French association
@nl
type
label
Fractionated doses of gemtuzum ...... te leukemia French association
@en
Fractionated doses of gemtuzum ...... te leukemia French association
@nl
prefLabel
Fractionated doses of gemtuzum ...... te leukemia French association
@en
Fractionated doses of gemtuzum ...... te leukemia French association
@nl
P2093
P2860
P50
P356
P1476
Fractionated doses of gemtuzum ...... te leukemia French association
@en
P2093
Celine Berthon
Claude Gardin
Cécile Pautas
Emmanuel Raffoux
Hassan Farhat
Leila Kammoun
Oumedaly Reman
Philippe Rousselot
Sylvie Castaigne
P2860
P356
10.1002/AJH.22201
P577
2011-11-10T00:00:00Z